Latest News

The Dangers of Inhalant Use Disorder
The Dangers of Inhalant Use Disorder

October 17th 2024

Inhalant use disorder is a form of substance use disorder characterized by the intentional inhalation of volatile substances for their psychoactive effects.

cocaine
A Randomized Controlled Trial of Lorcaserin in Cocaine Use Disorder

October 7th 2024

Adolescent Pregnancy and Parenting: Reducing Stigma and Improving Outcomes
Adolescent Pregnancy and Parenting: Reducing Stigma and Improving Outcomes

September 26th 2024

nitrous oxide
Galaxy Gas: The Dangerous Viral Trend

September 24th 2024

end of life
End-of-Life Care for Patients With Psychiatric Disorders

September 20th 2024

Latest CME Events & Activities

Updates on New and Emerging Therapies to Improve Outcomes for Patients With Major Depressive Disorder

View More

PER® Psychiatry Summit

November 7, 2024

View More

5th Annual International Congress on the Future of Neurology®

View More

2023 Annual Psychiatric Times™ World CME Conference

View More

Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II

View More

Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies

View More

Patient, Provider, and Caregiver Connection™: Exploring Unmet Needs In Postpartum Depression – Making the Case for Early Detection and Novel Treatments

View More

'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care

View More

Real Psychiatry 2025

January 17 - 18, 2025

View More

More Than ‘Blue’ After Birth: Managing Diagnosis and Treatment of Post-Partum Depression

View More

Patient, Provider & Caregiver Connection™: Reducing the Burden of Parkinson Disease Psychosis with Personalized Management Plans

View More

Expert Perspectives in the Recognition and Management of Postpartum Depression

View More

SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era

View More

Expert Illustrations & Commentaries™: New Targets for Treatment in Cognitive Impairment in Schizophrenia – The Role of NMDA Receptors and Co-agonists

View More

BURST CME™ Part I: Understanding the Impact of Huntington’s Disease

View More

Burst CME™ Part II: The Evolving Treatment Landscape for Huntington Disease

View More

Clinical ShowCase: Developing a Personalized Treatment Plan for a Patient with Huntington’s Disease Associated Chorea

View More

Stabilize and Thrive: Prioritizing Patient Success Through Novel Therapeutic Management in Schizophrenia

View More

More News

© 2024 MJH Life Sciences

All rights reserved.